Neurocrine Biosciences, Inc. (NBIX)

131.91 -0.47 (-0.36%) USD  |  NASDAQ  |  Mar 03, 13:18
More

Neurocrine Biosciences Total Equity Including Minority Interest (Quarterly)

Total Equity Including Minority Interest (Quarterly) Chart

View Total Equity Including Minority Interest (Quarterly) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Equity Including Minority Interest (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Equity Including Minority Interest (Quarterly) Range, Past 5 Years

View Total Equity Including Minority Interest (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Equity Including Minority Interest (Quarterly) Benchmarks

View Total Equity Including Minority Interest (Quarterly) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Edgewise Therapeutics, Inc. Upgrade
Nuvalent, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
CapsoVision, Inc. Upgrade